Published in Obesity and Diabetes Week, January 9th, 2006
In a recently published article, scientists in the United States conducted a study "to investigate the effect of a sustained (7-day) decrease in plasma free fatty acid (FFA) concentrations on insulin action and intramyocellular long-chain fatty acyl-CoAs (LCFA-CoAs), we studied the effect of acipimox, a potent inhibitor of lipolysis, in seven type 2 diabetic patients (age 53±3 years, BMI 30.2±2.0 kg/m2, fasting plasma glucose...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week